HomeAGMB โข NASDAQ
add
Agomab Therapeutics NV
Previous close
$16.02
Day range
$15.48 - $16.56
Year range
$12.66 - $16.56
Market cap
782.21M USD
Avg Volume
172.34K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
SABR
36.44%
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | โ | โ |
Operating expense | 11.81M | โ |
Net income | -11.73M | โ |
Net profit margin | โ | โ |
Earnings per share | โ | โ |
EBITDA | -11.80M | โ |
Effective tax rate | -0.03% | โ |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 171.46M | โ |
Total assets | 206.36M | โ |
Total liabilities | 18.28M | โ |
Total equity | 188.08M | โ |
Shares outstanding | 25.00K | โ |
Price to book | -0.00 | โ |
Return on assets | โ | โ |
Return on capital | โ | โ |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -11.73M | โ |
Cash from operations | -12.44M | โ |
Cash from investing | -363.00K | โ |
Cash from financing | 81.86M | โ |
Net change in cash | 68.86M | โ |
Free cash flow | โ | โ |
About
Founded
2017
Website
Employees
62